TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year EBIT Growth History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|
| EBIT Growth(%) | 32.26 | 127.18 | - |
What is the latest EBIT Growth ratio of TRIDENT LIFELINE ?
| Year | EBIT Growth |
|---|---|
| Mar2024 | 32.26 |
| Mar2023 | 127.18 |
| Mar2022 | - |
How is EBIT Growth of TRIDENT LIFELINE Trending?
| Years | EBIT Growth | % Change | |
|---|---|---|---|
| Mar2024 | 32.26 | -74.63 | |
| Mar2023 | 127.18 | 0 | |
| Mar2022 | 0 | - | |
Other Financial Ratios of TRIDENT LIFELINE
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹348.0 Cr | -2.9% | 3.5% | 1.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -2.9% |
3.5% |
1.7% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses